Background

The Food and Drug Administration has extended from Oct. 16 to Nov. 15 the period for public comment on a draft guidance on the information that will be provided to a person whose request for a certificate to a foreign government has been denied as well as the process for seeking review of such a denial. This draft guidance applies to medical devices manufactured in a registered establishment (i.e., FDA-approved, -cleared, or -exempted devices) that are exported from the U.S.

Copyright © 2021 Sandler, Travis & Rosenberg, P.A.; WorldTrade Interactive, Inc. All rights reserved.

ST&R: International Trade Law & Policy

Since 1977, we have set the standard for international trade lawyers and consultants, providing comprehensive and effective customs, import and export services to clients worldwide.

View Our Services 

Close

Cookie Consent

We use cookies on our website. By continuing to use our website, you agree to the Privacy Policy and Terms of Use.